The study revealed the synaptic paradox of the APOE-related risk of AD: surprisingly, it was APOE-e4, the gene variant that is linked to the highest risk of AD, that was most efficient in stimulating MAP signaling and in enhancing synaptogenesis. The gene discussed is APOE; the disease is Alzheimer disease.